Free Trial
→ Massive Data Leak Exposes 512,000-Line Code That Could Change Society Forever (From Chaikin Analytics) (Ad)tc pixel
OTCMKTS:HYPMY

Hypermarcas 3/12/2026 Earnings Report

Hypermarcas logo
$4.86 +0.06 (+1.25%)
As of 12:23 PM Eastern
ProfileEarnings HistoryForecast

Hypermarcas EPS Results

Actual EPS
$0.13
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Hypermarcas Revenue Results

Actual Revenue
$414.22 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Hypermarcas Announcement Details

Quarter
Date
3/12/2026
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Hypermarcas Earnings Headlines

Hypermarcas (OTCMKTS:HYPMY) Upgraded at Zacks Research
May 2, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30753840
Hypera S.A. (HYPMY) Q3 2025 Earnings Call Transcript
October 29, 2025  |  seekingalpha.comhttps://seekingalpha.com/article/4834950-hypera-s-a-hypmy-q3-2025-earnings-call-transcript
I was right about SpaceX
Jeff Brown predicted Bitcoin before it climbed as high as 52,400%, Tesla before 2,150%, and Nvidia before 32,000%. Now he says SpaceX is shaping up to be the biggest IPO of the decade - and three key milestones just confirmed it. In the past 21 days: SpaceX crossed 10,000 active satellites, Elon filed confidential IPO paperwork with the SEC, and another rocket launched 25 more satellites. Two-thirds of every satellite in orbit now belongs to one company. The public filing could drop any day.tc pixel
May 8 at 1:00 AM  |  Brownstone Research (Ad)
Brazil's Hypera announces new majority stakeholder group
July 7, 2025  |  reuters.comhttps://www.reuters.com/business/healthcare-pharmaceuticals/brazils-hypera-announces-new-majority-stakeholder-group-2025-07-07/
Hypera S.A. (HYPMY) Stock Price, Quote, News & Analysis - Seeking Alpha
June 29, 2025  |  seekingalpha.comhttps://seekingalpha.com/symbol/HYPMY
Hypera S.A. credit rating downgraded due to increased leverage
April 9, 2025  |  investing.comhttps://www.investing.com/news/stock-market-news/hypera-sa-credit-rating-downgraded-due-to-increased-leverage-93CH-3977909
See More Hypermarcas Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Hypermarcas? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Hypermarcas and other key companies, straight to your email.

About Hypermarcas

Hypermarcas (OTCMKTS:HYPMY) S.A. is a Brazil-based consumer health and pharmaceutical company whose shares trade over the counter in the United States under the symbol HYPMY. Founded in the early 2000s and headquartered in Rio de Janeiro, the company operates as a holding group for a broad portfolio of branded products in the healthcare and personal care sectors.

Through its various subsidiaries, Hypermarcas develops, manufactures and markets prescription and over-the-counter medications, alongside personal care, baby care, home care and nutritional supplement products. Its pharmaceutical lineup includes analgesics, anti-inflammatories, vitamins and dermatological preparations, while its consumer goods segment encompasses shampoos, soaps, lotions and oral hygiene items under multiple local brands.

Primarily focused on the domestic Brazilian market, Hypermarcas has also extended its reach into other Latin American countries via export partnerships and regional distributors. Over the years, the company has grown through acquisitions of smaller domestic drugmakers and consolidation of well-known local brands. Detailed executive leadership information is not widely available in public sources.

View Hypermarcas Profile
Earnings Tools